Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Aurinia Pharmaceuticals Inc (AUPH) had Operating Cash Flow per Share of $0.98 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$283.06M |
|
$287.20M |
|
$32.66M |
|
$250.39M |
|
$168.61M |
|
$114.44M |
|
$-0.29M |
|
$114.16M |
|
$114.16M |
|
$287.20M |
|
$287.20M |
|
$287.20M |
|
$287.20M |
|
$114.44M |
|
$133.89M |
|
134.37M |
|
138.70M |
|
$2.14 |
|
$2.07 |
|
| Balance Sheet Financials | |
$491.97M |
|
$2.11M |
|
$259.62M |
|
$751.59M |
|
$93.72M |
|
$52.32M |
|
$76.53M |
|
$170.26M |
|
$581.33M |
|
$577.57M |
|
$581.33M |
|
132.32M |
|
| Cash Flow Statement Financials | |
$135.66M |
|
$-32.77M |
|
$-106.11M |
|
$83.43M |
|
$80.21M |
|
$-3.22M |
|
$14.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.25 |
|
-- |
|
-- |
|
0.08 |
|
0.12 |
|
88.46% |
|
40.43% |
|
40.43% |
|
47.30% |
|
40.33% |
|
101.47% |
|
$135.41M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
0.71 |
|
6.83 |
|
53.45 |
|
49.40% |
|
49.73% |
|
38.21% |
|
45.32% |
|
$4.39 |
|
$0.98 |
|
|
Operating Cash Flow per Share |
$0.98 |